Upstart Moderna takes on outsized role in U.S. vaccine effort

The nation’s second coronavirus vaccine, produced by Moderna, could be on its way to thousands of sites nationwide by this weekend — a major accomplishment for a company that has never before brought a product to market.

An independent Food and Drug Administration advisory committee on Thursday endorsed the shot for adults 18 and over, and the agency is expected to issue an emergency use authorization on Friday.